With the right technologies and frameworks, we can meet regulatory obligations and protect consumers without sacrificing ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DataVisor, the world's leading AI-powered fraud and financial crime prevention platform, is excited to announce significant enhancements to its advanced ...

Sellas (NASDAQ:SLS) reported positive data from a Phase 2 study of its drug SLS009 in the treatment of patients with relapsed/refractory acute myeloid leukemia, or AML, with ASXL1 mutations. The study ...

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. Please note that ...

Primary endpoint of pivotal phase 2 study met with statistical significance in using Revumenib for the treatment of relapsed/refractory mNPM1 AML patients; sNDA expected 1st half 2025. PDUFA action ...

The European Data Protection Board (EDPB) held its 77th plenary meeting on 28 March 2023. The EDPB considered the following key topics: discussions on the Guidelines on data subject access right, ...

Kura Oncology and Kyowa Kirin announced that clinical data from the KOMET-007 trial, evaluating ziftomenib in combination with the standard chemotherapy regimen of cytarabine and daunorubicin (7+3) ...

The Council, represented by the Polish presidency of the Council of the EU, and the European Parliament secured a provisional deal on a new law which will improve cooperation between national data ...